TISSUE MMP-7 EXPRESSION PREDICTS SURVIVAL IN BLADDER CANCER PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY

被引：2
|
作者：
Szarvas, Tibor
Kramer, Gero
Hess, Jochen
Tschirdewahn, Stephan
Reis, Henning
Romics, Imre
Sevcenco, Sabina
Toetsch, Martin
Ruebben, Herbert
Dorp, Frank Vom
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1867
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1416
引用
收藏
页码：E575 / E575
页数：1
相关论文
共 50 条
  • [1] Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
    Fossa, SD
    Sternberg, C
    Scher, HI
    Theodore, CH
    Mead, B
    Dearnaley, D
    Roberts, JT
    Skovlund, E
    BRITISH JOURNAL OF CANCER, 1996, 74 (10) : 1655 - 1659
  • [2] MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
    Szarvas, Tibor
    Hoffmann, Michele J.
    Olah, Csilla
    Szekely, Eszter
    Kiss, Andras
    Hess, Jochen
    Tschirdewahn, Stephan
    Hadaschik, Boris
    Grotheer, Vera
    Nyirady, Peter
    Csizmarik, Anita
    Varadi, Melinda
    Reis, Henning
    DIAGNOSTICS, 2021, 11 (01)
  • [3] BRCA1 MRNA EXPRESSION IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY
    Gago Ramos, J. L.
    Font Pous, A.
    Ibarz Servio, L.
    Taron, M.
    Boix Orri, R.
    Celiz, P.
    Carrato, C.
    Saladie Roig, J. M.
    Rosell, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 256 - 256
  • [4] BRCA1 mRNA expression in patients (p) with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy
    Font, A.
    Taron, M.
    Costa, C.
    Layos, L.
    Perez-Roca, L.
    Sanchez, J.
    Chaib, I.
    Mora, M.
    Gago, J.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Jong Gwang Kim
    Baek-Yeol Ryoo
    Yeon Hee Park
    Bong-Seog Kim
    Tae-You Kim
    Young-Hyuck Im
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 301 - 307
  • [6] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Yeon Hee
    Kim, Bong-Seog
    Kim, Tae-You
    Im, Young-Hyuck
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) : 301 - 307
  • [7] Histologic subtypes of bladder cancer influence overall survival of patients treated by radical cystectomy and adjuvant cisplatin-based chemotherapy
    Keck, B.
    Taubert, H.
    Wach, S.
    Stoehr, R.
    Kunath, F.
    Bertz, S.
    Lehmann, J.
    Stoeckle, M.
    Hartmann, A.
    Wullich, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E868 - U828
  • [8] Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis
    Li, Gang
    Niu, Hui-min
    Wu, Hong-tao
    Lei, Bao-yu
    Wang, Xiao-hua
    Guo, Xiao-bo
    Feng, Shu-lin
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (02): : E81 - E94
  • [9] ELIGIBILITY OF PATIENTS WITH UROTHELIAL CANCER OF THE BLADDER FOR NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY
    Vemana, Goutham
    Sandhu, Gurdarshan
    Nepple, Kenneth
    Strope, Seth
    JOURNAL OF UROLOGY, 2013, 189 (04): : E54 - E54
  • [10] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
    Galsky, Matt D.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Moshier, Erin L.
    Sonpavde, Guru
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345